Walking about 7,000 steps a day is linked to a sharply lower risk of dying early and of developing several of the most feared chronic diseases, according to a large meta-analysis published in The Lancet Public Health in the summer of 2025.
Compared with people who managed only around 2,000 steps a day, those hitting roughly 7,000 had a 47 percent lower risk of all-cause mortality, a 25 percent lower risk of cardiovascular disease, a 38 percent lower risk of dementia, a 22 percent lower risk of depressive symptoms and a 28 percent lower risk of falls.
The team behind the review, led by researchers at the University of Sydney, argue that this figure is a more realistic benchmark for most adults than the widely cited 10,000-step target.
What the review actually looked at
The paper is a systematic review of 57 studies from 35 cohorts, with 31 of those studies pooled in the dose-response meta-analyses. The data spans participants in more than ten countries, including the United States, the United Kingdom, Australia and Japan, and covers device-measured step counts rather than self-reported estimates.
Also read: Morning workouts helped sleep and body fat, evening workouts helped blood vessels
The researchers looked at eight outcomes: all-cause death, cardiovascular disease incidence and mortality, cancer incidence and mortality, type 2 diabetes, dementia, depressive symptoms and falls.
Alongside the headline mortality number, the analysis found a 14 percent lower risk of type 2 diabetes at 7,000 steps versus 2,000, and a 37 percent lower risk of dying from cancer. The link to cancer incidence itself was more modest, at around 6 percent.
Where the extra 3,000 steps stop paying off
For most of the outcomes, the risk curve flattened as step counts climbed above 7,000. Ten thousand steps still helped, but the additional benefit over 7,000 was small for dementia, depression and overall mortality. Heart-disease risk was one of the outcomes that kept improving at higher step volumes.
"For people who are already active, 10,000 steps a day is great. But beyond 7000 steps, the extra benefits for most of the health outcomes we looked at were modest," said co-author Dr. Katherine Owen in a statement from the University of Sydney.
Also read: Three midlife risk factors tied to nearly 13 more dementia-free years, NYU study finds
Benefits were also visible well below 7,000 steps. The dose-response curve began bending downward from around 3,000 to 4,000 steps a day, meaning even modest increases from a sedentary baseline were linked to lower risk.
What the researchers say it means in practice
Professor Melody Ding, who led the work at the University of Sydney's School of Public Health, framed the result as encouragement rather than a new hurdle.
"Aiming for 7000 steps is a realistic goal based on our findings, which assessed health outcomes in a range of areas that hadn't been looked at before," Ding said in the university's release. "Our research helps to shift the focus from perfection to progress. Even small increases in daily movement can lead to meaningful health improvements."
Independent experts largely agreed. "The finding that doing 5000-7000 steps per day is an important addition to the literature which helps to debunk the myth that 10,000 steps per day should be the target," said Dr. Daniel Bailey of Brunel University of London in an expert reaction collected by the Science Media Centre.
Also read: Vitamin C does not prevent colds for most people, but daily use shortens them
A few caveats are worth keeping in mind. The included studies are observational, so they show associations rather than proof that walking a specific number of steps directly causes lower disease risk. Some outcomes, particularly cancer incidence and depressive symptoms, rested on a smaller pool of studies than the mortality analysis.
Still, the practical message is clear enough. If chasing 10,000 has felt like a chore, the current best evidence suggests you can ease off the pressure. Consistency at 7,000 appears to buy most of the payoff, and even shorter walks are far better than sitting still.
Also read: Zone 2 cardio isn't the mitochondrial upgrade influencers promised, new review finds